ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 120 filers reported holding ERASCA INC in Q4 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $495,000 | +12275.0% | 209,612 | +10967.2% | 0.00% | – |
| Q1 2024 | $4,000 | -92.6% | 1,894 | -92.5% | 0.00% | – |
| Q4 2023 | $54,000 | +100.0% | 25,317 | +86.9% | 0.00% | – |
| Q3 2023 | $27,000 | +17.4% | 13,549 | +61.0% | 0.00% | – |
| Q2 2023 | $23,000 | +91.7% | 8,418 | +108.2% | 0.00% | – |
| Q1 2023 | $12,000 | -62.5% | 4,044 | -45.0% | 0.00% | – |
| Q4 2022 | $32,000 | +433.3% | 7,349 | +827.9% | 0.00% | – |
| Q3 2022 | $6,000 | +200.0% | 792 | +116.4% | 0.00% | – |
| Q2 2022 | $2,000 | -99.3% | 366 | -98.9% | 0.00% | – |
| Q1 2022 | $279,000 | +316.4% | 32,442 | +653.6% | 0.00% | – |
| Q4 2021 | $67,000 | +36.7% | 4,305 | +85.7% | 0.00% | – |
| Q3 2021 | $49,000 | – | 2,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $95,078,000 | 13.59% |
| AH Equity Partners Bio II, L.L.C. | 2,500,000 | $21,500,000 | 12.39% |
| Cormorant Asset Management, LP | 10,505,554 | $90,348,000 | 6.94% |
| EDBI Pte Ltd | 888,888 | $7,644,000 | 5.09% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $2,688,000 | 1.94% |
| PFM Health Sciences, LP | 4,791,406 | $41,206,000 | 1.54% |
| Artal Group S.A. | 3,172,221 | $27,281,000 | 1.14% |
| AH Equity Partners V, L.L.C. | 50,000 | $430,000 | 1.02% |
| Orbimed Advisors | 1,667,693 | $14,342,000 | 0.23% |
| EcoR1 Capital, LLC | 678,441 | $5,835,000 | 0.18% |